SAMD13 serves as a useful prognostic biomarker for hepatocellular carcinoma
Abstract Hepatocellular carcinoma (HCC) is the most common form of liver cancer and the 5-year relative overall survival (OS) rate is less than 20%. Since there are no specific symptoms, most patients with HCC are diagnosed in an advanced stage with poor prognosis. Therefore, identifying novel progn...
Збережено в:
| Автори: | , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2023-11-01
|
| Серія: | European Journal of Medical Research |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1186/s40001-023-01347-5 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|